Global Pruritus Therapeutics Market Research Report 2017

December 2017 | 124 pages | ID: GF373815A43EN
QYResearch

Abstracts

In the last several years, global market of Pruritus Therapeutics developed smoothly, with an average growth rate of 4.8%. In 2016, global consumption value of Pruritus Therapeutics is nearly 10.8 billion USD.

This report studies Pruritus Therapeutics in Global market, especially in North America, Europe, China, Rest of Asia, focuses on top manufacturers in global market, with revenue and market share for each manufacturer, covering

• J&J
• Abbott
• Amgen
• LEO Pharma
• Novartis
• Bayer
• Pfizer
• UCB Pharma
• GlaxoSmithKline
• Galderma
• Huapont

Market Segment by Regions, this report splits Global into several key Regions, with revenue, market share and growth rate of Pruritus Therapeutics in these regions, from 2012 to 2022 (forecast), like

• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

Split by Product Types, with revenue market share and growth rate of each type, can be divided into

• Antihistamines
• Corticosteroids
• Calcineurin Inhibitors
• Other

Split by applications, this report focuses on revenue market share and growth rate of Pruritus Therapeutics in each application, can be divided into

• External Use
• Oral
• Injection

Contents

1 PRURITUS THERAPEUTICS MARKET OVERVIEW

1.1 Product Overview and Scope of Pruritus Therapeutics
1.2 Pruritus Therapeutics Segment by Types and Drugs Types
  1.2.1 Global Pruritus Therapeutics Revenue and Growth (%) Comparison by Types (2012-2022)
  1.2.2 Global Pruritus Therapeutics Revenue Market Share (%) by Types in 2016
  1.2.3 Corticosteroids
  1.2.4 Antihistamines
  1.2.5 Calcineurin Inhibitors
1.3 Pruritus Therapeutics Segment by Applications
  1.3.1 Global Pruritus Therapeutics Revenue Comparison by Applications (2012-2022)
  1.3.2 External Use
  1.3.3 Oral
  1.3.4 Injection
1.4 Pruritus Therapeutics Market by Regions
  1.4.1 Global Pruritus Therapeutics Market Size and Growth (%) Comparison by Regions
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Asia-Pacific Status and Prospect (2012-2022)
  1.4.4 Europe Status and Prospect (2012-2022)
  1.4.5 South America Status and Prospect (2012-2022)
  1.4.6 Middle East and Africa Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Pruritus Therapeutics (2012-2022)

2 GLOBAL PRURITUS THERAPEUTICS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Pruritus Therapeutics Revenue and Share by Manufacturers (2016 and 2017)
2.2 Global Pruritus Therapeutics Gross Profit and Share by Manufacturers (2016 and 2017)
2.3 Global Pruritus Therapeutics Gross Margin of Manufacturers (2016 and 2017)
2.4 Manufacturers Pruritus Therapeutics Headquarters, Founded Time
2.5 Pruritus Therapeutics Market Competitive Situation and Trends
  2.5.1 Pruritus Therapeutics Market Concentration Rate
  2.5.2 Pruritus Therapeutics Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL PRURITUS THERAPEUTICS REVENUE (VALUE) BY REGIONS (2012-2017)

3.1 Global Pruritus Therapeutics Revenue (Value) and Market Share by Regions (2012-2017)
3.2 Global Pruritus Therapeutics Gross Profit and Market Share by Regions (2012-2017)
3.3 Global Pruritus Therapeutics Revenue and Gross Margin (2012-2017)
3.4 North America Pruritus Therapeutics Revenue and Gross Margin (2012-2017)
3.5 Europe Pruritus Therapeutics Revenue and Gross Margin (2012-2017)
3.6 Asia-Pacific Pruritus Therapeutics Revenue and Gross Margin (2012-2017)
3.7 South America Pruritus Therapeutics Revenue and Gross Margin (2012-2017)
3.8 Middle East and Africa Pruritus Therapeutics Revenue and Gross Margin (2012-2017)

4 GLOBAL PRURITUS THERAPEUTICS REVENUE TREND BY TYPE

4.1 Global Pruritus Therapeutics Revenue and Market Share by Product Catalog (2012-2017)
4.2 Global Pruritus Therapeutics Revenue Growth by Type (2012-2017)

5 GLOBAL PRURITUS THERAPEUTICS MARKET ANALYSIS BY APPLICATIONS

5.1 Global Pruritus Therapeutics Revenue and Market Share by Applications (2012-2017)
5.2 Global Pruritus Therapeutics Revenue Growth Rate (%) by Applications (2012-2017)

6 ANALYSIS OF PRURITUS THERAPEUTICS INDUSTRY KEY MANUFACTURERS

6.1 J&J
  6.1.1 Company Profile
  6.1.2 Product Information
  6.1.3 Revenue, Gross Profit and Gross Margin
6.2 Abbott
  6.2.1 Company Profile
  6.2.2 Product Information
  6.2.3 Revenue, Gross Profit and Gross Margin
6.3 Amgen
  6.3.1 Company Profile
  6.3.2 Product Information
  6.3.3 Revenue, Gross Profit and Gross Margin
6.4 LEO Pharma
  6.4.1 Company Profile
  6.4.2 Product Information
  6.4.3 Revenue, Gross Profit and Gross Margin
6.5 Novartis
  6.5.1 Company Profile
  6.5.2 Product Information
  6.5.3 Revenue, Gross Profit and Gross Margin
6.6 Bayer
  6.6.1 Company Profile
  6.6.2 Product Information
  6.6.3 Revenue, Gross Profit and Gross Margin
6.7 Pfizer
  6.7.1 Company Profile
  6.7.2 Product Information
  6.7.3 Revenue, Gross Profit and Gross Margin
6.8 UCB Pharma
  6.8.1 Company Profile
  6.8.2 Product Information
  6.8.3 Revenue, Gross Profit and Gross Margin
6.9 GlaxoSmithKline
  6.9.1 Company Profile
  6.9.2 Product Information
  6.9.3 Revenue, Gross Profit and Gross Margin
6.10 Galderma
  6.10.1 Company Profile
  6.10.2 Product Information
  6.10.3 Revenue, Gross Profit and Gross Margin
6.11 Huapont
  6.11.1 Company Profile
  6.11.2 Product Information
  6.11.3 Revenue, Gross Profit and Gross Margin

7 PRURITUS THERAPEUTICS MANUFACTURING COST ANALYSIS

7.1 Pruritus Therapeutics R&D Cost Analysis
  7.1.1 Clinical Phase Costs
  7.1.2 Capitalized Costs
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
  7.2.4 Other Costs Analysis
7.3 Manufacturing Process Analysis of Pruritus Therapeutics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Pruritus Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Market Drivers
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 GLOBAL PRURITUS THERAPEUTICS MARKET FORECAST (2017-2022)

11.1 Global Pruritus Therapeutics Revenue Forecast (2017-2022)
11.2 Global Pruritus Therapeutics Revenue Forecast by Regions (2017-2022)
  11.2.1 North America Pruritus Therapeutics Revenue Forecast (2017-2022)
  11.2.2 Europe Pruritus Therapeutics and Revenue Forecast (2017-2022)
  11.2.3 Asia-Pacific Pruritus Therapeutics Revenue Forecast (2017-2022)
  11.2.4 South America Pruritus Therapeutics Revenue Forecast (2017-2022)
  11.2.5 Middle East and Africa Pruritus Therapeutics Revenue Forecast (2017-2022)
11.3 Global Pruritus Therapeutics Revenue Forecast by Type (2017-2022)
11.4 Global Pruritus Therapeutics Revenue Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Pruritus Therapeutics
Table Global Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Revenue Market Share of Pruritus Therapeutics by Types in 2016
Figure Product Picture of Corticosteroids
Figure Product Picture of Antihistamines
Figure Product Picture of Calcineurin Inhibitors
Table Global Pruritus Therapeutics Revenue (M USD) Comparison by Applications (2012-2022)
Figure Pruritus Therapeutics Revenue Market Share by Applications in 2016
Figure External Use Examples
Figure Oral Examples
Figure Injection Examples
Table Global Market Pruritus Therapeutics Revenue (M USD) Comparison by Regions 2012-2022
Figure North America Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)
Figure Europe Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)
Figure South America Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)
Figure Middle East and Africa Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)
Figure Global Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)
Table Global Pruritus Therapeutics Revenue (M USD) by Manufacturers (2016 and 2017)
Table Global Pruritus Therapeutics Revenue Share by Manufacturers (2016 and 2017)
Figure 2016 Global Pruritus Therapeutics Revenue Share by Manufacturers
Figure 2017 Global Pruritus Therapeutics Revenue Share by Manufacturers
Table Global Pruritus Therapeutics Gross Profit (M USD) of Key Manufacturers (2016 and 2017)
Table Global Pruritus Therapeutics Gross Profit Share by Manufacturers (2016 and 2017)
Figure 2016 Pruritus Therapeutics Gross Profit Share by Manufacturers
Figure 2017 Pruritus Therapeutics Gross Profit Share by Manufacturers
Table Global Market Pruritus Therapeutics Gross Margin of Key Manufacturers (2016 and 2017)
Figure Global Market Pruritus Therapeutics Gross Margin of Key Manufacturers in 2016
Figure Global Market Pruritus Therapeutics Gross Margin of Key Manufacturers in 2017
Table Manufacturers Pruritus Therapeutics Headquarters and Founded Time
Figure Pruritus Therapeutics Revenue Market Concentration Rate in 2016
Figure Pruritus Therapeutics Revenue Market Share of Top 3 Manufacturers in 2016
Figure Pruritus Therapeutics Revenue Market Share of Top 5 Manufacturers in 2016
Table Mergers & Acquisitions, Expansion
Table Global Pruritus Therapeutics Revenue (M USD) by Regions (2012-2017)
Table Global Pruritus Therapeutics Revenue Market Share by Regions (2012-2017)
Figure 2012-2017 Global Pruritus Therapeutics Revenue Market Share by Regions
Table 2016 Global Pruritus Therapeutics Revenue Market Share by Regions
Table Global Pruritus Therapeutics Gross Profit (M USD) by Regions (2012-2017)
Figure Global Pruritus Therapeutics Gross Profit and Market Share by Regions (2012-2017)
Figure 2012-2017 Global Pruritus Therapeutics Gross Profit Market Share by Regions
Table 2016 Global Pruritus Therapeutics Gross Profit Market Share by Regions
Table Global Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)
Table North America Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)
Table Europe Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)
Table Asia-Pacific Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)
Table South America Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)
Table Middle East and Africa Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)
Table Global Pruritus Therapeutics Revenue (M USD) by Product Catalog (2012-2017)
Table Global Pruritus Therapeutics Revenue Share (%) by Product Catalog (2012-2017)
Figure Revenue Market Share (%) of Pruritus Therapeutics by Product Catalog (2012-2017)
Figure 2016 Revenue Market Share (%) of Pruritus Therapeutics by Product Catalog
Figure Global Pruritus Therapeutics Revenue Growth (%) by Type (2012-2017)
Table Global Pruritus Therapeutics Revenue (M USD) by Applications (2012-2017)
Table Global Pruritus Therapeutics Revenue Market Share (%) by Applications (2012-2017)
Figure Global Pruritus Therapeutics Revenue Market Share (%) by Applications (2012-2017)
Figure Global Pruritus Therapeutics Revenue Market Share (%) by Applications in 2016
Table Global Pruritus Therapeutics Revenue Growth Rate (%) by Applications (2012-2017)
Figure Global Pruritus Therapeutics Revenue Growth Rate (%) by Applications (2012-2017)
Table J&J Company Profile
Figure Pruritus Therapeutics Product Introduction of J&J
Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of J&J 2016-2017
Table Abbott Company Profile
Figure Pruritus Therapeutics Product Introduction of Abbott
Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Abbott 2016-2017
Table Amgen Company Profile
Figure Pruritus Therapeutics Product Introduction of Amgen
Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Amgen 2016-2017
Table LEO Pharma Company Profile
Figure Pruritus Therapeutics Product Introduction of LEO Pharma
Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of LEO Pharma 2016-2017
Table Novartis Company Profile
Figure Pruritus Therapeutics Product Introduction of Novartis
Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Novartis 2016-2017
Table Bayer Company Profile
Figure Pruritus Therapeutics Product Introduction of Bayer
Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Bayer 2016-2017
Table Pfizer Company Profile
Figure Pruritus Therapeutics Product Introduction of Pfizer
Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Pfizer 2016-2017
Table UCB Pharma Company Profile
Figure Pruritus Therapeutics Product Introduction of UCB Pharma
Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of UCB Pharma 2016-2017
Table GlaxoSmithKline Company Profile
Figure Pruritus Therapeutics Product Introduction of GlaxoSmithKline
Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of GlaxoSmithKline 2016-2017
Table Galderma Company Profile
Figure Pruritus Therapeutics Product Introduction of Galderma
Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Galderma 2016-2017
Table Huapont Company Profile
Figure Pruritus Therapeutics Product Introduction of Huapont
Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Huapont 2016-2017
Figure Typical Phases from Research to the Market for a Drug Candidate
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Pruritus Therapeutics Compound
Table Capitalized Preclinical and Clinical Period Costs per Investigational Pruritus Therapeutics Compound
Table Manufacturing Cost Structure of Pruritus Therapeutics
Figure Brazil Overview of Average Monthly Wages 2015-2016 (BRL/Month)
Figure Argentina Overview of Average Monthly Wages 2012-2016 (ARS/Month)
Figure Mexico Overview of Average Monthly Wages 2012-2016(MXN/Day)
Figure USA Labor Cost Analysis
Figure Cost of Employing a Factory Worker
Figure 2016 Estimated Labour Costs for the Whole Economy in EuropeR
Figure Monthly Minimum Wages in Asia 2016
Figure China Labor Costs
Table Average Price of Electricity to Ultimate Customers
Figure Electricity Prices for Household Consumers in 2016
Figure Summary of the Driving Assumptions
Figure Industrial Electric Rates 2016 (PER KWH)
Figure Manufacturing Process Analysis of Pruritus Therapeutics
Figure Pruritus Therapeutics Industrial Chain Analysis
Table Major Buyers of Pruritus Therapeutics
Figure Marketing Channel for Pruritus Therapeutics
Table Distributors/Traders List
Table Market Drivers of Pruritus Therapeutics
Figure Global GDP Growth Rate for 2015
Figure US GDP 2006-2016 (Billion USD)
Figure US CPI Change 2016-2017
Figure EU GDP 2006-2016 (Billion USD)
Figure EU CPI Change 2012-2016
Figure Germany GDP 2006-2016 (Billion USD)
Figure Germany CPI Change 2016-2017
Figure UK GDP 2006-2016 (Billion USD)
Figure UK CPI Change 2016-2017
Figure Italy GDP 2006-2016 (Billion USD)
Figure Italy CPI Change 2016-2017
Figure Japan GDP 2006-2016 (Billion USD)
Figure Japan CPI Change 2012-2016
Figure China GDP 2006-2016 (Billion USD)
Figure China CPI Change 2016-2017
Figure Global Pruritus Therapeutics Revenue (M USD) and Growth Rate Forecast (2017-2022)
Table Global Pruritus Therapeutics Revenue (M USD) Forecast by Regions (2017-2022)
Figure Global Pruritus Therapeutics Revenue Forecast by Regions (2017-2022)
Figure North America Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
Figure Europe Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
Figure Asia-Pacific Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
Figure South America Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
Figure Middle East and Africa Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
Table Global Pruritus Therapeutics Revenue (M USD) Forecast by Product Catalog (2017-2022)
Figure Global Pruritus Therapeutics Revenue Market Share (%) Forecast by Product Catalog (2017-2022)
Table Global Pruritus Therapeutics Revenue (M USD) Forecast by Application (2017-2022)
Figure Global Pruritus Therapeutics Revenue Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources